Investigation and control of an outbreak of Achromobacter xylosoxidans bacteremia

Infection Control and Hospital Epidemiology

Volumn 33, Issue 2, 2012, Pages 180-184

  Behrens Muller, Brie ^a   Conway, Judith ^a   Yoder, Jonathan ^b   Conover, Craig S ^a  

^a ILLINOIS DEPARTMENT OF PUBLIC HEALTH   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MORPHINE;

ACHROMOBACTER XYLOSOXIDANS; ARTICLE; BACTEREMIA; BINOMIAL DISTRIBUTION; CONTROLLED STUDY; EPIDEMIC; HUMAN; INFECTION CONTROL; PATIENT CONTROLLED ANALGESIA; RISK FACTOR;

ACHROMOBACTER DENITRIFICANS; ADULT; AGED; AGED, 80 AND OVER; ANALGESIA, PATIENT-CONTROLLED; BACTEREMIA; CASE-CONTROL STUDIES; CROSS INFECTION; DISEASE OUTBREAKS; EQUIPMENT CONTAMINATION; FEMALE; FOMITES; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; ILLINOIS; INFECTION CONTROL; MALE; MIDDLE AGED; ODDS RATIO; RISK FACTORS;

EID: 84855547780     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/663710     Document Type: Article

References (20)

1. Spear JB, Fuhrer J, Kirby BD. Achromobacter xylosoxidans (Al-calagines xylosoxidans subsp. xylosoxidans) bacteremia associated with a well-water source: case report and review of the literature. J Clin Microbiol 1988;26:598-599.
2. Wang J, Chen M, Lin YE, et al. Association between contaminated faucets and colonization or infection by nonfermenting gram-negative bacteria in intensive care units in Taiwan. J Clin Microbiol 2009;47(10):3226-3230.
3. Steinberg JP, Burd EM. Other gram-negative and gram-variable bacilli. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. 7th ed. Philadelphia: Churchill Livingstone, 2010.
4. De Baets F, Schelstraete P, Van Daele S, Haerynck F, Vaneech-outte M. Achromobacter xylosoxidans in cystic fibrosis: prevalence and clinical relevance. J Cyst Fibros 2007;6(1):75-78.
5. Kanellopoulou M, Pournaras S, Iglezos H, Skarmoutsou N, Papafrangas E, Maniatis AN. Persistent colonization of nine cystic fibrosis patients with an Achromobacter (Alcaligenes) xylo-soxidans clone. Eur J Clin Microbiol Infect Dis 2004;23(4): 336-339.
6. Tena D, Carranza R, Barbera ́ JR, Valdezate S, Garrancho JM, Arranz M, Sàez-Nieto JA. Outbreak of long-term intravascular catheter-related bacteremia due to Achromobacter xylosoxidans subspecies xylosoxidans in a hemodialysis unit. Eur J Clin Mi-crobiol Infect Dis 2005;24(11):727-732.
7. Kim MJ, Bancroft E, Lehnkering E, Donlan R, Mascola L. Al-caligenes xylosoxidans bloodstream infections in outpatient oncology office. Emerg Infect Dis 2008;14(7):1046-1052.
8. Vu-Thien H, Darbord JC, Moissenet D, Dulot C, Dufourcq JB, Marsol P, Garbarg-Chenon A. Investigation of an outbreak of wound infections due to Alcaligenes xylosoxidans transmitted by chlorhexidine in a burn unit. Eur J Clin Microbiol Infect Dis 1998;17:724-726.
9. Ribot EM, Fair MA, Gautom R, Cameron DN, Hunter SB, Swa-minathan B, Barrett TJ. Standardization of pulsed-field gel elec-trophoresis protocols for the subtyping of Escherichia coli O157: H7, Salmonella, and Shigella for PulseNet. Foodborne Pathog Dis 2006;3(1):59-67.
10. Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Mi-crobiol 1995;33:2233-2239.
11. Binomial calculator. http://www.stat.tamu.edu/west/applets/binomialdemo.html. Accessed April 29, 2011.
12. Larson EL, Cimiotti JP, Haas J, et al. Gram-negative bacilli associated with catheter-associated and non-catheter-associated bloodstream infections and hand carriage by healthcare workers in neonatal intensive care units. Pediatr Crit Care Med 2005;6: 457-461.
13. Substance Abuse and Mental Health Services Administration, Office of Applied Studies (OAS). Preliminary Results from the 1996 National Household Survey on Drug Abuse. Rockville, MD: OAS series #H-13, DHHS Publication No. (SMA) 97-3149; 1997.
14. Public Health Citizens Research Group. Questionable doctors. http://www.citizen.org/hrg/qdsite/map.htm. Accessed April 30, 2011.
15. Sullivan E, Decker P. Effective Leadership and Management in Nursing. Upper Saddle River, NJ: Prentice Hall, 2001.
16. Ostrowsky BE, Whitener C, Bredenberg HK, et al. Serratia mar-cescens bacteremia traced to an infused narcotic. N Engl J Med 2002;346:1529-1537.
17. Maki DG, Klein BS, McCormick RD, et al. Nosocomial Pseu-domonas picketti bacteremias traced to narcotic tampering. JAMA 1991;265:981-986.
18. McGrath T. Addicted docs put patients in peril: random drug screening urged for health care workers. MSNBC. http://www.msnbc.msn.com/id/37396390/ns/health-addictions//. Updated June 24, 2010. Accessed April 30, 2011.
19. American Hospital Association. Substance Abuse Policies for Health Care Institutions. Chicago: Management Advisory Human Resources, American Hospital Association, 1992.
20. American Medical Association (AMA) Council on Scientific Affairs. Issues in Employee Drug Testing. Chicago: AMA Policy 95.984, CSA Report A, I-90; 1990.